At the end of December 2019, Chinese public health authorities reported several cases of acute respiratory syndrome in Wuhan City, Hubei province, China. Chinese scientists soon identified a novel coronavirus as the main causative agent. The disease is now referred to as coronavirus disease 2019 (COVID-19), and the causative virus is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is a new strain of coronavirus that has not been previously identified in humans.

The initial outbreak in Wuhan spread rapidly, affecting other parts of China. Cases were soon detected in several other countries. Outbreaks and clusters of the disease have since been observed in Asia, Europe, Australia, Africa and the Americas.

For a quick overview, please refer to the following pages:


The COVID-19 pandemic is rapidly evolving, and outbreak investigations are ongoing. ECDC is closely monitoring this outbreak, providing risk assessments, public health guidance, and advice on response activities to EU Member States and the EU Commission.

Latest updates


Rapid risk assessment: Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – seventh update

Risk assessment -


Download today’s data on the geographic distribution of COVID-19 cases worldwide

Table -


Communicable disease threats report, 29 March-4 April 2020, week 14

Publication -


An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA

Technical report -


Contact tracing: Public health management of persons, including healthcare workers, having had contact with COVID-19 cases in the European Union – first update

Technical report -

Situation update 6 April 2020, dataset collected 6:00-10:00 CET

1 244 421 cases
68 796 deaths
Whereof 47 741 deaths in the EU/EEA and the UK.
582 554 cases
in the EU/EEA and the UK.